Winter routines often mean less movement, heavier meals, disrupted sleep, and more social events. For women in perimenopause and menopause, weight gain around the abdomen can feel especially stubborn due to hormonal shifts, reduced muscle mass, and increased insulin resistance.
Some women are finding that combining menopausal hormone therapy (MHT, also known as HRT) with GLP-1 medicines, under specialist supervision, can support healthier weight loss outcomes and improve metabolic health [1][2].
Why menopause weight gain is different
As oestrogen declines, fat storage tends to shift toward the abdomen. Metabolism can slow, muscle mass may decrease, and insulin sensitivity can worsen. These changes increase the risk of type 2 diabetes and cardiovascular disease [3].
How GLP-1 medicines work
GLP-1 receptor agonists, such as semaglutide, help regulate appetite and blood sugar. They can reduce hunger, increase fullness, and support weight loss when combined with lifestyle changes [1][2].
How hormone therapy supports metabolism
Oestrogen has roles in insulin sensitivity, fat metabolism, sleep quality and inflammation. For some women, optimised HRT can support energy, help reduce symptoms that disrupt sleep and exercise routines, and support healthier metabolic patterns. It is not a weight loss drug, but it can remove barriers that make weight management harder [3].
Why the combination can help some women
In clinical discussions, the combination may help for two reasons. HRT can support symptom stability and metabolic health, while GLP-1 medicines directly reduce appetite and improve glucose regulation. Together, they may support more consistent progress for women dealing with menopause-related metabolic resistance [4].
Winter and festive tips that support results
- Keep protein consistent at meals to protect muscle and support satiety.
- Plan indulgences, avoid all-day grazing, especially on low sleep days.
- Walk daily where possible, even 10 to 20 minutes helps blood sugar.
- Hydrate between social events, thirst can mimic hunger.
- Protect sleep, poor sleep increases cravings and hunger hormones.
Safety and medical guidance
Both HRT and GLP-1 medicines require personalised clinical assessment, including your medical history, cardiovascular risk, and suitability for treatment. Always use these therapies under appropriate prescribing and monitoring [2][3].
Specialist support in Hertfordshire
The Menopause Medic offers personalised menopause and metabolic support in Berkhamsted and St Albans, and via remote consultations for women across Hertfordshire and beyond.
References
[1] NICE, Semaglutide for managing overweight and obesity: https://www.nice.org.uk/guidance/ta875
[2] NICE, Tirzepatide for managing overweight and obesity: https://www.nice.org.uk/guidance/ta1026
[3] NICE NG23, Menopause: diagnosis and management: https://www.nice.org.uk/guidance/ng23
[4] British Menopause Society, guidance on incretin-based therapies and women using HRT: https://thebms.org.uk